Category: General

Mexico Legalizes Medical Cannabis - Here's How You Can Profit

Posted on by The INO.com Team

Analysis originally distributed on June 21, 2017 By: Michael Vodicka of Cannabis Stock Trades

Legal cannabis scored another big victory this week.

In April, Mexico's lower parliament overwhelmingly voted to legalize medical cannabis, voting 357 to 7.

Then, earlier this week, Mexico's President Enrique Pena Nieto signed the bill into law, legalizing the use of medicinal cannabis THC, CBD, and all cannabis derivatives. The new legislation also makes it legal to produce and distribute cannabis for medical and therapeutic purposes.

Early estimates project sales between $1 billion and $2 billion in the first 10 years. That would come out to between $100 and $200 million per year.

The size of Mexico's young cannabis market will pale in comparison to the US and Canada.

In 2016, US cannabis sales totaled $6.5 billion. Continue reading "Mexico Legalizes Medical Cannabis - Here's How You Can Profit" →

Weekly Futures Recap With Mike Seery

Posted on by The INO.com Team

We've asked Michael Seery of SEERYFUTURES.COM to give our INO readers a weekly recap of the Futures market. He has been Senior Analyst for close to 15 years and has extensive knowledge of all of the commodity and option markets.

Michael frequently appears on multiple business networks including Bloomberg news, Fox Business, CNBC Worldwide, CNN Business, and Bloomberg TV. He is also a guest on First Business, which is a national and internationally syndicated business show.

Gold Futures

Gold futures in the August contract settled last Friday in New York at 1,256 an ounce while currently trading at 1,256 in a pretty uneventful trading week. I'm not currently involved in this market, but I'm looking at a possible short position in next week's trade. Gold prices hit a 5-week low in Wednesday's trade. However, the 10-day high stands at 1,284 which is a little too far away in my opinion so I will wait for the chart structure to tighten up with a rally or a couple more days off the calendar then I will be looking at getting short. I'm still bearish gold and the precious metals in general. The next major level support is at 1,225 with prices trading right at their 20 & 100-day moving average telling you that there is no trend at this time. The commodity markets, in general, remain weak except for the stock market which continues to move higher. I am also recommending a bullish position in the Dow Jones as I still think money flows will enter that market & out all the gold market in the coming weeks, so keep a close eye on this market for a possible short position.
TREND: MIXED
CHART STRUCTURE: IMPROVING
Continue reading "Weekly Futures Recap With Mike Seery" →

Secret CBD Company Grows Sales 1,300% in 12 Months

Posted on by The INO.com Team

Analysis originally distributed on June 15, 2017 By: Michael Vodicka of Cannabis Stock Trades

In the old days, pot was seen as a way to get stoned.

But now, researchers are discovering that pot can actually have many health benefits.

Most of those come from Cannabidiol - one of the most prevalent compounds found in hemp plants that is commonly refereed to as CBD on the Street.

Studies have shown that the non-psychoactive elements of CBD can deliver relief to a wide range of ailments, including aches, pains, anxiety, insomnia and arthritis - without the euphoric effects provided by THC.

These benefits are creating a huge growth market.

The Hemp Business Journal, a CBD media and data company, estimates the CBD market will grow to $2.1 billion in consumer sales by 2020. That would be a 700% increase from 2016.

This is an exciting segment of the cannabis industry that doesn't get a lot of attention. Continue reading "Secret CBD Company Grows Sales 1,300% in 12 Months" →

Weekly Futures Recap With Mike Seery

Posted on by The INO.com Team

We've asked Michael Seery of SEERYFUTURES.COM to give our INO readers a weekly recap of the Futures market. He has been Senior Analyst for close to 15 years and has extensive knowledge of all of the commodity and option markets.

Michael frequently appears on multiple business networks including Bloomberg news, Fox Business, CNBC Worldwide, CNN Business, and Bloomberg TV. He is also a guest on First Business, which is a national and internationally syndicated business show.

Gold Futures

Gold prices settled last Friday in New York at 1,271 an ounce while currently trading at 1,256 down about $15 for the trading week and topping out at the 1,300 level. The Federal Reserve announced that they raised interest rates a .25 point and plan on raising interest rates further down the road and this sent gold prices to a three-week low. I am not involved in any of the precious metals as they have been incredibly choppy in 2017 and the monetary risk and the risk/reward has not met my criteria as prices are now trading below their 20 and 100-day moving average. I'm advising clients to avoid this sector and gold at the present time. The commodity markets, in general, remain weak in my opinion except for a select few with the stock market continuing to move higher taking money flows out of the gold and moving them into the Dow Jones once again. I think that trend will continue despite the terrorist attacks happening on a weekly basis coupled with uncertainty worldwide. Prices seem to have one more leg lower to the downside with a possible retest of 1,215 in my opinion. Silver prices this week also went into the negative as those prices remain extremely choppy as well, but one day the trends will come back in the metals so keep a close eye on this market & wait for the chart structure to improve.
TREND: MIXED - LOWER
CHART STRUCTURE: POOR
Continue reading "Weekly Futures Recap With Mike Seery" →

A 2nd Cannabis Stock With $1 Billion Drug Potential

Posted on by The INO.com Team

Analysis originally distributed on June 7, 2017 By: Michael Vodicka of Cannabis Stock Trades

Blockbuster drugs are the holy grail of the pharmaceutical and biotech industry.

When annual sales of a new drug break the $1 billion mark, investors are usually rewarded with big gains.

This is what began happening late 2012 with Gilead Science (NASDAQ:GILD).

In 2013 the FDA approved Gilead's hepatitis C drug Sovaldi.

Then, in 2014, Gilead scored an FDA approval for another Hep C drug, Harvoni.

Both drugs went on to quickly hit blockbuster status - sending shares of Gilead soaring - jumping more than 200% in the next two years. Take a look below.

GILD
Image courtesy of MarketClub.com

Today, the young cannabis industry is in hot pursuit of its first ever cannabis blockbuster - and I expect the winner of this race to deliver huge gains to shareholders. Continue reading "A 2nd Cannabis Stock With $1 Billion Drug Potential" →